Warfarin product now substitutable due to scarcity

Coumadin 5mg tablets is the subject of a new Serious Scarcity Substitution Instrument In early March, the Therapeutic Goods Administration issued an advisory that several warfarin products were in shortage, due to manufacturing issues, including Coumadin (warfarin sodium) 2mg and 5mg tablets. While supply of some strengths has improved since, the TGA now says that